[
  {
    "ts": null,
    "headline": "Is Hologic Set for Growth After FDA Clears New Diagnostic Platform?",
    "summary": "Trying to figure out whether Hologic deserves a place in your portfolio? You are not alone. Investors find themselves re-examining the stock as the healthcare sector bounces between bouts of optimism and caution, sparked by shifting market tides and pockets of innovation. Over the past week, Hologic’s price nudged up by 1.9%, and while the past month’s 2.7% gain catches the eye, the real story lurks in the longer stretch: down 4.7% year-to-date, with a 14.7% slide over the past year. Yet, if...",
    "url": "https://finnhub.io/api/news?id=1ec01d46b50133c54ec259489843dc6f6fb9412ae327ba3c7eb1132e01e00f54",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760001027,
      "headline": "Is Hologic Set for Growth After FDA Clears New Diagnostic Platform?",
      "id": 137030615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Trying to figure out whether Hologic deserves a place in your portfolio? You are not alone. Investors find themselves re-examining the stock as the healthcare sector bounces between bouts of optimism and caution, sparked by shifting market tides and pockets of innovation. Over the past week, Hologic’s price nudged up by 1.9%, and while the past month’s 2.7% gain catches the eye, the real story lurks in the longer stretch: down 4.7% year-to-date, with a 14.7% slide over the past year. Yet, if...",
      "url": "https://finnhub.io/api/news?id=1ec01d46b50133c54ec259489843dc6f6fb9412ae327ba3c7eb1132e01e00f54"
    }
  },
  {
    "ts": null,
    "headline": "What Hologic (HOLX)'s FDA Clearance for GI Assays Means for Shareholders",
    "summary": "Hologic recently received FDA 510(k) clearance and CE marking in Europe for its Panther Fusion GI Bacterial and Expanded Bacterial Assays, expanding its molecular diagnostic capabilities for infectious gastroenteritis and advancing laboratory workflows globally. This regulatory achievement highlights Hologic’s continued investment in rapid, highly sensitive diagnostic technologies that address significant global healthcare challenges, complementing its momentum in breast health innovation...",
    "url": "https://finnhub.io/api/news?id=976f7b0e97649b95a38bbd28cb5905afa40bf3375485f9479bd39a0f574cd734",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759979220,
      "headline": "What Hologic (HOLX)'s FDA Clearance for GI Assays Means for Shareholders",
      "id": 137028593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Hologic recently received FDA 510(k) clearance and CE marking in Europe for its Panther Fusion GI Bacterial and Expanded Bacterial Assays, expanding its molecular diagnostic capabilities for infectious gastroenteritis and advancing laboratory workflows globally. This regulatory achievement highlights Hologic’s continued investment in rapid, highly sensitive diagnostic technologies that address significant global healthcare challenges, complementing its momentum in breast health innovation...",
      "url": "https://finnhub.io/api/news?id=976f7b0e97649b95a38bbd28cb5905afa40bf3375485f9479bd39a0f574cd734"
    }
  }
]